Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * Sitemap: https://www.imfinzi.com/sitemap.xml Disallow: /reg/ Disallow: /404-error.html Disallow: /404-error Disallow: /login/ Disallow: /thank-you.html Disallow: /thank-you-savings.html Disallow: /thank-you-fto.html Disallow: /site-exit.html Disallow: /SiteExit Disallow: /content-area/ Disallow: /swf Disallow: /thank-you Disallow: /500-error Disallow: /content/PhysicianServices Disallow: /content/dam/physician-services Disallow: /content/MobileServices Disallow: /content/dam/mobile-services Disallow: /content/MedicalServices Disallow: /content/dam/medical-services Disallow: /etc/tags Disallow: /content/campaigns Disallow: |
Title | Immunotherapy for BTC, uHCC, NSCLC & ES-SCLC – IMFINZI® |
Description | IMFINZI is an immunotherapy that is approved to treat certain IMFINZI® (durvalumab) is an immunotherapy approved to treat patients with unresectable hepatocellular carcinoma, bile duct cancer, gallbladder cancer, unresectable Stage 3 NSCLC, Stage 4 NSCLC, and extensive-stage |
Keywords | N/A |
WebSite | imfinzi.com |
Host IP | 54.230.162.106 |
Location | United States |
Site | Rank |
US$55,890,709
Last updated: 2023-05-13 08:28:59
imfinzi.com has Semrush global rank of 189,375. imfinzi.com has an estimated worth of US$ 55,890,709, based on its estimated Ads revenue. imfinzi.com receives approximately 6,448,928 unique visitors each day. Its web server is located in United States, with IP address 54.230.162.106. According to SiteAdvisor, imfinzi.com is safe to visit. |
Purchase/Sale Value | US$55,890,709 |
Daily Ads Revenue | US$51,592 |
Monthly Ads Revenue | US$1,547,743 |
Yearly Ads Revenue | US$18,572,913 |
Daily Unique Visitors | 429,929 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
imfinzi.com. | A | 299 | IP: 54.230.162.106 |
imfinzi.com. | A | 299 | IP: 54.230.162.20 |
imfinzi.com. | A | 299 | IP: 54.230.162.64 |
imfinzi.com. | A | 299 | IP: 54.230.162.4 |
imfinzi.com. | NS | 86400 | NS Record: ns-1705.awsdns-21.co.uk. |
imfinzi.com. | NS | 86400 | NS Record: ns-724.awsdns-26.net. |
imfinzi.com. | NS | 86400 | NS Record: ns-1417.awsdns-49.org. |
imfinzi.com. | NS | 86400 | NS Record: ns-151.awsdns-18.com. |
imfinzi.com. | MX | 300 | MX Record: 10 custmx.cscdns.net. |
imfinzi.com. | TXT | 300 | TXT Record: facebook-domain-verification=8753q35dlrfsr5rmh1na4rcwtmh2iw |
Cholangiocarcinoma or Gallbladder Cancer Select a Cancer Type --> Non-Small Cell Lung Cancer (NSCLC) Extensive-Stage Small Cell Lung Cancer (ES-SCLC) Bile Duct Cancer and Gallbladder Cancer Unresectable Hepatocellular Carcinoma (uHCC) Prescribing Information IMFINZI Prescribing Information IMJUDO Prescribing Information Patient Information --> Patient Information IMFINZI Patient Information IMJUDO Patient Information See All Approved Uses Visit Healthcare Professionals Site Select Your Cancer Type Non-Small Cell Lung Cancer (NSCLC) Extensive-Stage Small Cell Lung Cancer (ES-SCLC) Bile Duct Cancer and Gallbladder Cancer Unresectable Hepatocellular Carcinoma (uHCC) Registration Successful... null you have successfully logged registered and logged in SIGN UP FOR SUPPORT Now Approved --> IMFINZI is an immunotherapy that is approved to treat certain cancers Now Approved --> IMFINZI is an immunotherapy that is approved to treat certain cancers SELECT YOUR CANCER TYPE Non-Small |
HTTP/1.1 403 Forbidden Server: CloudFront Date: Tue, 21 Dec 2021 01:39:10 GMT Content-Type: text/html Content-Length: 919 Connection: keep-alive X-Cache: Error from cloudfront Via: 1.1 2b873f743281511e290d4958008561c2.cloudfront.net (CloudFront) X-Amz-Cf-Pop: EWR53-C3 X-Amz-Cf-Id: __Wi1E67jvxyK3X_ZHL9DDGw3KRahhHdhQVsF79KVDzs0B72rn91_A== |
Domain Name: IMFINZI.COM Registry Domain ID: 1924841632_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.corporatedomains.com Registrar URL: http://cscdbs.com Updated Date: 2021-04-26T05:19:22Z Creation Date: 2015-04-30T20:29:37Z Registry Expiry Date: 2022-04-30T20:29:37Z Registrar: CSC Corporate Domains, Inc. Registrar IANA ID: 299 Registrar Abuse Contact Email: domainabuse@cscglobal.com Registrar Abuse Contact Phone: 8887802723 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS-1417.AWSDNS-49.ORG Name Server: NS-151.AWSDNS-18.COM Name Server: NS-1705.AWSDNS-21.CO.UK Name Server: NS-724.AWSDNS-26.NET DNSSEC: unsigned >>> Last update of whois database: 2021-12-24T07:50:51Z <<< |